Blog story by Vanessa Perberdy, IFPMA and Herb Riband, Access Accelerated

As the drive toward Universal Health Coverage (UHC) and the 2030 Sustainable Development Goals (SDGs) intensifies, so too does the urgency to respond to the mounting burden of NCDs, especially in low- and middle-income countries (LMICs) where their impact is most acute.

Of the 41 million NCD-related deaths per year globally, 77% are in LMICs. The innovative pharmaceutical industry is a decades-long partner in helping to address the needs of people living with NCDs, collaborating with more than 500 global health stakeholders to act on NCDs, accelerate UHC, and achieve the SDGs.


Read the full blog story on the Global Week for Action on NCDs website.